000 01600 a2200361 4500
005 20250513121846.0
264 0 _c19970715
008 199707s 0 0 eng d
022 _a0937-941X
024 7 _a10.1007/BF01674813
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aClarkson, T B
245 0 0 _aGonadal hormone substitutes: effects on the cardiovascular system.
_h[electronic resource]
260 _bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
_c1997
300 _aS43-51 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aCoronary Disease
_xphysiopathology
650 0 4 _aCoronary Vessels
_xdrug effects
650 0 4 _aEstrogen Antagonists
_xtherapeutic use
650 0 4 _aEstrogen Replacement Therapy
650 0 4 _aEstrogens
_xagonists
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aPiperidines
_xtherapeutic use
650 0 4 _aRaloxifene Hydrochloride
650 0 4 _aTamoxifen
_xanalogs & derivatives
700 1 _aCline, J M
700 1 _aWilliams, J K
700 1 _aAnthony, M S
773 0 _tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
_gvol. 7 Suppl 1
_gp. S43-51
856 4 0 _uhttps://doi.org/10.1007/BF01674813
_zAvailable from publisher's website
999 _c9186128
_d9186128